PL BioScience
PrivateLast Round
Series A
Aug 8, 2024
Total Funding Raised
$13.06M
Momentum Score
25 /100
Company Overview
PL BioScience GmbH is a German biotechnology company that develops and manufactures animal-free cell culture media. Founded in 2015 as a spin-off from RWTH Aachen University, the company specializes in producing Human Platelet Lysate (HPL) as a superior, xeno-free alternative to Fetal Bovine Serum (FBS). Their proprietary ELAREM™ Platform Technology provides high-quality growth supplements for various applications, including academic research, pre-clinical studies, and the development of cell therapies in regenerative medicine. The company is venture-backed and announced a major expansion of its headquarters and manufacturing facilities in Aachen in 2025 to meet growing global demand.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PL BioScience Comps
Public and private peers based on sector, stage, and business model.
PL BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 8, 2024 | ||||
| Series A | May 25, 2021 |
Key People
Founding team and executive leadership
PL BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Better Ventures | Series A |
| Born2grow | Series A |
| b.value AG | Series A |
| AVANT BIO | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Exclusive agreement with Summit Pharmaceuticals International Corporation for the Japanese market.
- Dec 22, 2025
Added Iwai Chem, a chemicals/life sciences distributor, as a customer.
PL BioScience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PL BioScience's valuation, stock price, and market status.
